Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study
- PMID: 36175872
- PMCID: PMC9520098
- DOI: 10.1186/s12954-022-00692-8
Access to needles and syringes and methadone maintenance therapy among people who inject drugs in Yangon, Myanmar: a qualitative study
Abstract
Background: Access to sterile needles, syringes and methadone maintenance therapy (MMT) is critical to reduce the prevalence of bloodborne virus infections among people who inject drugs (PWID). We aimed to explore the experiences of PWID with respect to accessing needles/syringes services and MMT in Yangon, Myanmar.
Methods: Burnet Institute implemented a community-based hepatitis C testing and treatment (CT2) program for PWID with on-site needles and syringes distribution. Separate from CT2, MMT was available at two government-run sites in Yangon. We conducted in-depth interviews with 15 PWID who received hepatitis C care in this program. Interviews were transcribed verbatim and translated into English. Thematic data analysis was performed using NVivo12 software.
Results: Self-reported changes to needles/syringes sharing behaviour after hepatitis C education in the CT2 program and commencement of treatment were observed. One third of participants reported they became aware of the risks of sharing and reusing needles/syringes, and consequently refrained from sharing after the CT2 program. Inadequate availability of NSPs, cost of needles/syringes, and issues maintaining privacy when accessing needles/syringes emerged as key barriers to accessibility of needles/syringes. Participants described difficulties in accessing free needles/syringes. They were not aware of other free needles/syringes services at the time of the interview. Purchasing needles/syringes from pharmacies had privacy and confidentiality concerns. Structural barriers to accessibility of MMT were identified for both MMT sites in Yangon. Of the two MMT sites in Yangon, participants reported that the Ywarthargyi center had strict eligibility criteria for take-home methadone and transportation issues as it was located in the outskirt of the town. The Thingyangyun center was in a more convenient location, but only offered daily observed doses and had a long waiting time which was burdensome for some employed participants.
Conclusion: Expansion of free needles/syringes services and adaptations of MMT to consider the needs and individual preferences of PWID will improve their access to these services and would likely reduce injecting related harms.
Keywords: Methadone; Needles and syringes; People who inject drugs.
© 2022. The Author(s).
Conflict of interest statement
MH has received investigator-initiated grant funding from Gilead Sciences and AbbVie for unrelated work. WLY has received Gilead Sciences Fellowship for related work.
References
-
- United Nations Office on Drugs and Crime (UNODC). World drug report 2021; 2021.
-
- Harm Reduction International. The global state of harm reduction 2018; 2018.
-
- Platt L, Minozzi S, Reed J, Vickerman P, Hagan H, French C, et al. Needle and syringe programmes and opioid substitution therapy for preventing HCV transmission among people who inject drugs: findings from a Cochrane review and meta-analysis. Addiction (Abingdon, England) 2018;113(3):545–563. doi: 10.1111/add.14012. - DOI - PMC - PubMed
-
- National AIDS Program (Ministry of Health and Sports). Myanmar integrated biological and behavioural surveillance survey and population size estimates among people who inject drugs (PWID): 2017–2018; 2019.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
